clotrimazole: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
clotrimazole: clinical details
Prescribing considerations
- Confirm that the formulation matches the site and licensed role.
- Before self-treatment of vaginal symptoms, assess a first episode, frequent recurrence, STI risk, pregnancy, age outside the product’s stated range or diagnostic uncertainty.
- Consider an alternative diagnosis for foul-smelling or blood-stained discharge, irregular bleeding, genital lesions, dysuria, lower abdominal pain, fever, gastrointestinal symptoms or worsening with treatment.
- Account for local irritants and allergens, including propylene glycol in the spray and cetostearyl alcohol or benzyl alcohol in selected creams.
- Counsel about reduced reliability of latex barrier contraception with vaginal and external thrush formulations.
Contraindications and cautions
- Hypersensitivity to clotrimazole or any formulation excipient.
- Do not use intravaginal products during menstruation.
- Avoid spray contact with eyes, ears and mucous membranes, inhalation and use near flames.
Monitoring
- Review persistent, worsening or recurrent symptoms and reconsider the diagnosis or organism.
- With oral tacrolimus or sirolimus, monitor for toxicity and consider measuring blood concentrations.
Clinical pharmacology
Clotrimazole is an imidazole antifungal that inhibits ergosterol synthesis, disrupting fungal membrane structure and function. Absorption through skin is minimal; vaginal administration also produces low systemic exposure.
Formulation and product differences
- Dermatological spray is for cutaneous infection and is useful on large or hairy areas.
- External thrush cream treats candidal vulvitis and does not replace treatment of candidal vaginitis.
- Internal cream is administered intravaginally using its supplied applicator.
- Pessaries and vaginal tablets require vaginal moisture to dissolve.
- Soft vaginal capsules are another intravaginal formulation and may be packaged with external cream.
clotrimazole preparations and strengths
Cream
Route: Cutaneous
Strengths: 1% w/w, 2% w/w
Pessary
Route: Vaginal
Strengths: 100 mg, 200 mg, 500 mg
clotrimazole interactions
Clinically important interactions depend on the formulation.
Latex condoms and diaphragms
Vaginal and external thrush products may damage latex and reduce contraceptive protection; use an alternative precaution as directed in the pack.
Oral tacrolimus or sirolimus
Vaginal clotrimazole may increase blood concentrations, so toxicity assessment and drug-level monitoring may be required.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.